What’s new

Stay Informed: Discover the Latest News and Updates on Healthcare Innovations and Breakthroughs at RemediumOne.

š—„š—²š—ŗš—²š—±š—¶š˜‚š—ŗš—¢š—»š—² š—®š˜ š—šš—£š—›š—¦ šŸ®šŸ¬šŸ®šŸ± – š——š—æš—¶š˜ƒš—¶š—»š—“ š—œš—»š—»š—¼š˜ƒš—®š˜š—¶š—¼š—» š—¶š—» š—©š—²š—°š˜š—¼š—æ-š—•š—¼š—æš—»š—² š——š—¶š˜€š—²š—®š˜€š—² š—£š—æš—²š˜ƒš—²š—»š˜š—¶š—¼š—»
July 22, 2025
U.S. FDA Approves KERENDIA (finerenone) to treat patients with left ventricular ejection fraction ≄ 40%
July 17, 2025
RemediumOne Joins as Founding Member of the COGNITUM ARO Consortium
June 24, 2025
Site initiation visit for the COLCARDIO-ACS study
June 20, 2025
ACT-GLOBAL Trial Discussion
June 13, 2025
FDA Approves GMRx2: First Triple-Combination Therapy for Initial Hypertension Treatment
June 12, 2025
1 2 3 7